Zhang WD - Search Results

1

CD47: Beyond an immune checkpoint in cancer treatment.

Bian HT, Shen YW, Zhou YD, Nagle DG, Guan YY, Zhang WD, Luan X. Bian HT, et al. Among authors: zhang wd. Biochim Biophys Acta Rev Cancer. 2022 Sep;1877(5):188771. doi: 10.1016/j.bbcan.2022.188771. Epub 2022 Aug 2. Biochim Biophys Acta Rev Cancer. 2022. PMID: 35931392 Review.

2

NFAT as cancer target: mission possible?

Qin JJ, Nag S, Wang W, Zhou J, Zhang WD, Wang H, Zhang R. Qin JJ, et al. Among authors: zhang r, zhang wd. Biochim Biophys Acta. 2014 Dec;1846(2):297-311. doi: 10.1016/j.bbcan.2014.07.009. Epub 2014 Jul 26. Biochim Biophys Acta. 2014. PMID: 25072963 Free PMC article. Review.

3

The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG.

Lv C, Zeng HW, Wang JX, Yuan X, Zhang C, Fang T, Yang PM, Wu T, Zhou YD, Nagle DG, Zhang WD. Lv C, et al. Among authors: zhang c, zhang wd. Cell Death Dis. 2018 Feb 7;9(2):165. doi: 10.1038/s41419-017-0247-5. Cell Death Dis. 2018. PMID: 29416003 Free PMC article.

4

Genus Liparis: A review of its traditional uses in China, phytochemistry and pharmacology.

Liang W, Guo X, Nagle DG, Zhang WD, Tian XH. Liang W, et al. Among authors: zhang wd. J Ethnopharmacol. 2019 Apr 24;234:154-171. doi: 10.1016/j.jep.2019.01.021. Epub 2019 Jan 26. J Ethnopharmacol. 2019. PMID: 30695705 Review.

5

Synergistic Mechanisms of Constituents in Herbal Extracts during Intestinal Absorption: Focus on Natural Occurring Nanoparticles.

Zhao Q, Luan X, Zheng M, Tian XH, Zhao J, Zhang WD, Ma BL. Zhao Q, et al. Among authors: zhang wd. Pharmaceutics. 2020 Feb 3;12(2):128. doi: 10.3390/pharmaceutics12020128. Pharmaceutics. 2020. PMID: 32028739 Free PMC article. Review.

6

Compound-based Chinese medicine formula: From discovery to compatibility mechanism.

Luan X, Zhang LJ, Li XQ, Rahman K, Zhang H, Chen HZ, Zhang WD. Luan X, et al. Among authors: zhang lj, zhang wd, zhang h. J Ethnopharmacol. 2020 May 23;254:112687. doi: 10.1016/j.jep.2020.112687. Epub 2020 Feb 24. J Ethnopharmacol. 2020. PMID: 32105748 Review.

7

Cytotoxic and antitumor peptides as novel chemotherapeutics.

Luan X, Wu Y, Shen YW, Zhang H, Zhou YD, Chen HZ, Nagle DG, Zhang WD. Luan X, et al. Among authors: zhang wd, zhang h. Nat Prod Rep. 2021 Jan 1;38(1):7-17. doi: 10.1039/d0np00019a. Epub 2020 Aug 10. Nat Prod Rep. 2021. PMID: 32776055 Free PMC article. Review.

8

Blocking CTGF-Mediated Tumor-Stroma Interplay in Pancreatic Cancer.

Shen YW, Zhou YD, Luan X, Zhang WD. Shen YW, et al. Among authors: zhang wd. Trends Mol Med. 2020 Dec;26(12):1064-1067. doi: 10.1016/j.molmed.2020.08.005. Epub 2020 Sep 11. Trends Mol Med. 2020. PMID: 32928643

9

The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination.

Jin J, Wu Y, Chen J, Shen Y, Zhang L, Zhang H, Chen L, Yuan H, Chen H, Zhang W, Luan X. Jin J, et al. Theranostics. 2020 Aug 8;10(22):10141-10153. doi: 10.7150/thno.46985. eCollection 2020. Theranostics. 2020. PMID: 32929339 Free PMC article. Review.

10

Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity.

Shen YW, Zhou YD, Chen HZ, Luan X, Zhang WD. Shen YW, et al. Among authors: zhang wd. Trends Cancer. 2021 Jun;7(6):511-524. doi: 10.1016/j.trecan.2020.12.001. Epub 2020 Dec 25. Trends Cancer. 2021. PMID: 33358571 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

853 results

Search Page